Neoadjuvant atezolizumab in resectable NSCLC patients: Immunophenotyping results from the interim analysis of the multicenter trial LCMC3 Meeting Abstract
| Authors: | Oezkan, F.; He, K.; Owen, D.; Pietrzak, M.; Cho, J. H.; Kitzler, R.; Pearson, R.; Rusch, V.; Chaft, J.; Suh, R.; Blasberg, J.; Reckamp, K.; Raz, D.; Kneuertz, P.; Fiorillo, L.; Garon, E.; Nicholas, A.; Johnson, A.; Schulze, K.; Grindheim, J.; Banchereau, R.; Phan, S.; Bunn, P. Jr; Kwiatkowski, D.; Johnson, B.; Kris, M.; Wistuba, I.; Lee, J.; Lozanski, G.; Carbone, D. |
| Abstract Title: | Neoadjuvant atezolizumab in resectable NSCLC patients: Immunophenotyping results from the interim analysis of the multicenter trial LCMC3 |
| Meeting Title: | 20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC) |
| Keywords: | immunophenotyping; nsclc; neoadjuvant anti-pd-l1 treatment |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 14 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2019 Sept 7-10 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-10-01 |
| Start Page: | S242 |
| End Page: | S243 |
| Language: | English |
| ACCESSION: | WOS:000492162201167 |
| DOI: | 10.1016/j.jtho.2019.08.482 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: OA13.07 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
